Comparative pharmacoeconomic assessment of apixaban vs. standard of care for the prevention of stroke in Italian atrial fibrillation patients. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 15, n. 1S, p. 15–26, 2014. DOI: 10.7175/fe.v15i1s.974. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/974. Acesso em: 29 oct. 2025.